Takeshi Kusunoki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Takeshi Kusunoki has a total of 169 co-authors. Here are the top co-authors by number of shared publications:
Katsuhisa Ikeda
Department of Otorhinolaryngology, Juntendo Tokyo Koto Geriatric Medical Center
22 shared publicationsKiyotaka Murata
Department of Otolaryngology, Kinki University School of Medicine, Osaka
22 shared publicationsRyo Wada
Department of Pathology, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, Japan
13 shared publicationsHirotomo Homma
Department of Pathology, Juntendo University of Medicine, Shizuoka Hospital, Shizuoka
10 shared publicationsYoshinobu Kidokoro
Department of Otorhinolaryngology, Juntendo University of Medicine, Shizuoka Hospital, Shizuoka
10 shared publicationsAya Yanai
Department of Otorhinolaryngology, Juntendo University of Medicine, Shizuoka Hospital
8 shared publications
Latest Publications
- Open Access
- 18 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1780245
Evaluating antioxidant treatment approaches for eosinophilic chronic sinusitis
Chronic rhinosinusitis with eosinophilia (ECRS) is a refractory sinusitis characterized by eosinophilia in the nasal mucosa and peripheral blood. In ECRS, multiple nasal polyps are present in the ethmoid sinuses, and the disease is often accompanied by olfactory dysfunction and asthma. It is a disease that significantly impairs the quality of life of patients by causing persistent nasal congestion and thick nasal discharge, leading to decreased concentration and insomnia. From previous studies, we found that (1) defects in Cu,Zn-SOD in ECRS epithelium contribute to increased IL-17A, macrophage infiltration in the subepithelial tissue, and excessive production of mucin gene (MUC5AC) in the epithelium, thereby potentially exacerbating inflammation and excessive mucus secretion, and (2) reduced HO-1 expression in the epithelium and macrophage infiltration are associated with epithelial damage in CRS accompanied by eosinophil infiltration. These findings suggest that antioxidants may play a crucial role in elucidating the pathophysiology of refractory diseases such as ECRS and may provide new therapeutic strategies. In this paper, three new comprehensive molecular signaling pathway networks of (1) oxidative stress, (2) inflammation inhibition mechanisms and (3) inflammation in ECRS were developed for the first time, based on a critical analysis of scientific literature. In addition, three immunology flowsheets related to oxidative stress, inflammation and carbon monoxide-based inflammation inhibition mechanisms of ECRS were developed for the first time and examined from both clinical and biochemical perspectives. Based on these pathways, this study identified the treatment targets which can be used in future ECRS treatments.
- 18 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1780245
Open AccessEvaluating antioxidant treatment approaches for eosinophilic chronic sinusitis
Chronic rhinosinusitis with eosinophilia (ECRS) is a refractory sinusitis characterized by eosinophilia in the nasal mucosa and peripheral blood. In ECRS, multiple nasal polyps are present in the ethmoid sinuses, and the disease is often accompanied by olfactory dysfunction and asthma. It is a disease that significantly impairs the quality of life of patients by causing persistent nasal congestion and thick nasal discharge, leading to decreased concentration and insomnia. From previous studies, we found that (1) defects in Cu,Zn-SOD in ECRS epithelium contribute to increased IL-17A, macrophage infiltration in the subepithelial tissue, and excessive production of mucin gene (MUC5AC) in the epithelium, thereby potentially exacerbating inflammation and excessive mucus secretion, and (2) reduced HO-1 expression in the epithelium and macrophage infiltration are associated with epithelial damage in CRS accompanied by eosinophil infiltration. These findings suggest that antioxidants may play a crucial role in elucidating the pathophysiology of refractory diseases such as ECRS and may provide new therapeutic strategies. In this paper, three new comprehensive molecular signaling pathway networks of (1) oxidative stress, (2) inflammation inhibition mechanisms and (3) inflammation in ECRS were developed for the first time, based on a critical analysis of scientific literature. In addition, three immunology flowsheets related to oxidative stress, inflammation and carbon monoxide-based inflammation inhibition mechanisms of ECRS were developed for the first time and examined from both clinical and biochemical perspectives. Based on these pathways, this study identified the treatment targets which can be used in future ECRS treatments.
- Open Access
- 14 December 2025
- Published by MDPI AG in Journal of Otorhinolaryngology, Hearing and Balance Medicine
- Vol. 6 (2) , 25
Efficacy of Combined Hyperbaric Oxygen, per Os Steroid, and Prostaglandin E1 Therapy for Idiopathic Sudden Sensorineural Hearing Loss and Prognostic Factors for Recovery
Background: Idiopathic sudden sensorineural hearing loss (ISSNHL) is an abrupt unilateral hearing loss of unknown origin. Combination therapy with hyperbaric oxygen (HBO), systemic steroids (SS), and prostaglandin E1 (PGE1) has been used in Japan; however, its prognostic factors remain unclear. Objective: To evaluate the efficacy of HBO combined with SS and PGE1 and to identify prognostic factors for hearing recovery in patients with ISSNHL. Methods: This retrospective study included 116 patients treated within 14 days of ISSNHL onset. Sixty patients received HBO, SS, and PGE1 (HBO group), and 56 received SS and PGE1 alone (No-HBO group). Hearing outcomes were assessed using PTA (arithmetic mean hearing at 250–4000 Hz) and graded by Siegel’s criteria. Prognostic factors were analyzed by multivariate logistic regression. Results: The HBO group showed significantly better hearing grade outcomes (p = 0.007) and greater PTA improvement (p = 0.003) than the No-HBO group. Vertigo and higher initial PTA were identified as independent predictors of poor hearing outcomes. Patients without vertigo showed significantly greater improvement at 2000 Hz (p = 0.009). Receiver operating characteristic analysis revealed an optimal initial PTA cutoff of ≥90.5 dB for predicting poor hearing outcome. Conclusions: HBO combined with SS and PGE1 significantly improves hearing outcomes in ISSNHL. However, the presence of vertigo and severe initial hearing loss remain poor prognostic indicators. These findings suggest that while the addition of HBO may enhance hearing outcomes, prognosis remains limited in severe cases. Further prospective studies are needed to confirm these results.
- 14 December 2025
- Published by MDPI AG in Journal of Otorhinolaryngology, Hearing and Balance Medicine
- Vol. 6 (2) , 25
Open AccessEfficacy of Combined Hyperbaric Oxygen, per Os Steroid, and Prostaglandin E1 Therapy for Idiopathic Sudden Sensorineural Hearing Loss and Prognostic Factors for Recovery
Background: Idiopathic sudden sensorineural hearing loss (ISSNHL) is an abrupt unilateral hearing loss of unknown origin. Combination therapy with hyperbaric oxygen (HBO), systemic steroids (SS), and prostaglandin E1 (PGE1) has been used in Japan; however, its prognostic factors remain unclear. Objective: To evaluate the efficacy of HBO combined with SS and PGE1 and to identify prognostic factors for hearing recovery in patients with ISSNHL. Methods: This retrospective study included 116 patients treated within 14 days of ISSNHL onset. Sixty patients received HBO, SS, and PGE1 (HBO group), and 56 received SS and PGE1 alone (No-HBO group). Hearing outcomes were assessed using PTA (arithmetic mean hearing at 250–4000 Hz) and graded by Siegel’s criteria. Prognostic factors were analyzed by multivariate logistic regression. Results: The HBO group showed significantly better hearing grade outcomes (p = 0.007) and greater PTA improvement (p = 0.003) than the No-HBO group. Vertigo and higher initial PTA were identified as independent predictors of poor hearing outcomes. Patients without vertigo showed significantly greater improvement at 2000 Hz (p = 0.009). Receiver operating characteristic analysis revealed an optimal initial PTA cutoff of ≥90.5 dB for predicting poor hearing outcome. Conclusions: HBO combined with SS and PGE1 significantly improves hearing outcomes in ISSNHL. However, the presence of vertigo and severe initial hearing loss remain poor prognostic indicators. These findings suggest that while the addition of HBO may enhance hearing outcomes, prognosis remains limited in severe cases. Further prospective studies are needed to confirm these results.
- Open Access
- 19 January 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (1) , e260917
Primary nasal neuroendocrine carcinoma in an older adult
Neuroendocrine carcinoma has a poor prognosis as it is highly malignant and prone to metastasis. It is relatively rare in the head and neck region, and no standard treatment has been established. Here, we report a case of primary neuroendocrine cancer of the nasal cavity in an elderly adult. This case is reported along with the clinical findings, imaging evaluation, treatment course and literature considerations.
- 19 January 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (1) , e260917
Open AccessPrimary nasal neuroendocrine carcinoma in an older adult
Neuroendocrine carcinoma has a poor prognosis as it is highly malignant and prone to metastasis. It is relatively rare in the head and neck region, and no standard treatment has been established. Here, we report a case of primary neuroendocrine cancer of the nasal cavity in an elderly adult. This case is reported along with the clinical findings, imaging evaluation, treatment course and literature considerations.
- Open Access
- 15 December 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (12) , e262363
Preoperative bilateral recurrent laryngeal nerve palsy in Graves’ disease
Malignant thyroid lesions may be accompanied by tracheal stenosis and recurrent laryngeal nerve palsy.1 However, benign thyroid disease may also lead to vocal cord paralysis.2 3 Here, we report a case of Graves’ disease with bilateral recurrent laryngeal nerve palsy and tracheal stenosis.
- 15 December 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (12) , e262363
Open AccessPreoperative bilateral recurrent laryngeal nerve palsy in Graves’ disease
Malignant thyroid lesions may be accompanied by tracheal stenosis and recurrent laryngeal nerve palsy.1 However, benign thyroid disease may also lead to vocal cord paralysis.2 3 Here, we report a case of Graves’ disease with bilateral recurrent laryngeal nerve palsy and tracheal stenosis.
- 19 February 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (2) , e256747
Case with translating to multiple myeloma at 8 years after radiation therapy for extramedullary plasmacytoma of the larynx
We report a case of extramedullary plasmacytoma of the larynx that was eradicated by radiotherapy; however, 8 years later, the disease had progressed to multiple myeloma. A mid -60s Japanese woman presented with a right-sided arytenoid mass in the larynx who underwent biopsy at another hospital. Based on the biopsy results, the patient was diagnosed with extramedullary plasma cell tumour and was referred to the Department of Otorhinolaryngology at our hospital. She received radiotherapy (50.4 Gy) and the laryngeal tumour was eradicated. Positron emission tomography/CT (PET-CT) revealed no abnormal accumulation in the larynx or whole body. After radiotherapy, the department of otorhinolaryngology, in consultation with Ddepartment of haematology performed follow-ups using laryngoscope, blood examination and PET-CT. Five years after the end of radiotherapy, the patient had no local recurrence or transition to multiple myeloma. However, 8 years later, blood examination and PET-CT revealed multiple myeloma. Laryngoscopy did not reveal any recurrent laryngeal tumour. Therefore, chemotherapy for multiple myeloma was administered at the department of haematology. Three months after the initiation of chemotherapy, the accumulation had disappeared in PET-CT. Three years have passed since chemotherapy initiation. At present, no recurrence or metastasis was observed in the larynx or whole body.
- 19 February 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (2) , e256747
Case with translating to multiple myeloma at 8 years after radiation therapy for extramedullary plasmacytoma of the larynx
We report a case of extramedullary plasmacytoma of the larynx that was eradicated by radiotherapy; however, 8 years later, the disease had progressed to multiple myeloma. A mid -60s Japanese woman presented with a right-sided arytenoid mass in the larynx who underwent biopsy at another hospital. Based on the biopsy results, the patient was diagnosed with extramedullary plasma cell tumour and was referred to the Department of Otorhinolaryngology at our hospital. She received radiotherapy (50.4 Gy) and the laryngeal tumour was eradicated. Positron emission tomography/CT (PET-CT) revealed no abnormal accumulation in the larynx or whole body. After radiotherapy, the department of otorhinolaryngology, in consultation with Ddepartment of haematology performed follow-ups using laryngoscope, blood examination and PET-CT. Five years after the end of radiotherapy, the patient had no local recurrence or transition to multiple myeloma. However, 8 years later, blood examination and PET-CT revealed multiple myeloma. Laryngoscopy did not reveal any recurrent laryngeal tumour. Therefore, chemotherapy for multiple myeloma was administered at the department of haematology. Three months after the initiation of chemotherapy, the accumulation had disappeared in PET-CT. Three years have passed since chemotherapy initiation. At present, no recurrence or metastasis was observed in the larynx or whole body.
- 9 January 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (1) , e258227
Emergency surgery for a giant laryngeal granuloma that caused dyspnoea
- 9 January 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (1) , e258227
Emergency surgery for a giant laryngeal granuloma that caused dyspnoea
- Open Access
- 30 December 2022
- Published by SciVision Publishers LLC in Case Reports and Reviews
- Vol. 3 (2)
A Case of Primary Malignant Lymphoma of The Tongue
We experienced a very rare case of primary malignant lymphoma of the tongue. The patient was an 83-year-old Japanese woman. Her chief complaint was swelling of the tongue for half a year. Fine needle biopsy from her tongue mass was performed at a previous hospital and showed no malignant cells. This hospital introduced her to our hospital for the purpose of scrutiny.At the first visit to our Department of Otorhinolaryngology, the tongue surface showed no erosion or ulcer, but hard tumors were palpable in the subepithelium of the central region of the tongue. Open biopsy of this tumor was performed and was diagnosed as T-cell lymphoma. PET-CT revealed no metastasis findings and bone marrow biopsy showed abnormal findings. This lymphoma was classified as Stage I (Ann Arbor classification). We consulted the Department of Hematology and she received chemotherapy by hematologists. Two years have passed since the start of chemotherapy. At present, this lymphoma shows no growth in the tongue or whole body
- 30 December 2022
- Published by SciVision Publishers LLC in Case Reports and Reviews
- Vol. 3 (2)
Open AccessA Case of Primary Malignant Lymphoma of The Tongue
We experienced a very rare case of primary malignant lymphoma of the tongue. The patient was an 83-year-old Japanese woman. Her chief complaint was swelling of the tongue for half a year. Fine needle biopsy from her tongue mass was performed at a previous hospital and showed no malignant cells. This hospital introduced her to our hospital for the purpose of scrutiny.At the first visit to our Department of Otorhinolaryngology, the tongue surface showed no erosion or ulcer, but hard tumors were palpable in the subepithelium of the central region of the tongue. Open biopsy of this tumor was performed and was diagnosed as T-cell lymphoma. PET-CT revealed no metastasis findings and bone marrow biopsy showed abnormal findings. This lymphoma was classified as Stage I (Ann Arbor classification). We consulted the Department of Hematology and she received chemotherapy by hematologists. Two years have passed since the start of chemotherapy. At present, this lymphoma shows no growth in the tongue or whole body
- Open Access
- 6 September 2022
- Published by BMJ in BMJ Case Reports
- Vol. 15 (9) , e250411
Case of anterior glottic web with bilateral vocal cord cancers
We experienced a case of anterior glottic web with bilateral vocal cord cancers. The laryngoscopic findings showed milky tumour lesions on bilateral vocal cords and a web-like formation with an adhesion in the anterior commissure. In this case, we performed laryngomicrosurgery to remove the bilateral vocal cord tumours and the anterior glottic web. This case was diagnosed as bilateral glottic carcinoma (laryngeal carcinoma TNM classification: pT1bN0M0) with an anterior glottic web. Therefore, this patient underwent radiation therapy (66 Gy). At present, one and a half years have passed since the end of radiotherapy. There is no recurrence of the glottic cancer or web. The airway at the glottis was patent. It has been reported that cutting-off the anterior glottic web could easily lead to readhesion. Accordingly, we continued to follow-up to determine whether there was a recurrence of readhesion of the anterior glottic web or glottic cancer.
- 6 September 2022
- Published by BMJ in BMJ Case Reports
- Vol. 15 (9) , e250411
Open AccessCase of anterior glottic web with bilateral vocal cord cancers
We experienced a case of anterior glottic web with bilateral vocal cord cancers. The laryngoscopic findings showed milky tumour lesions on bilateral vocal cords and a web-like formation with an adhesion in the anterior commissure. In this case, we performed laryngomicrosurgery to remove the bilateral vocal cord tumours and the anterior glottic web. This case was diagnosed as bilateral glottic carcinoma (laryngeal carcinoma TNM classification: pT1bN0M0) with an anterior glottic web. Therefore, this patient underwent radiation therapy (66 Gy). At present, one and a half years have passed since the end of radiotherapy. There is no recurrence of the glottic cancer or web. The airway at the glottis was patent. It has been reported that cutting-off the anterior glottic web could easily lead to readhesion. Accordingly, we continued to follow-up to determine whether there was a recurrence of readhesion of the anterior glottic web or glottic cancer.
- Open Access
- 29 January 2021
- Published by MDPI AG in Clinics and Practice
- Vol. 11 (1) , 43-46
A Case of Nasopharyngeal Tuberculosis with Cervical Lymph Node Tuberculosis Suspected of Cervical Malignant Disease at the First Examination
A case of nasopharyngeal tuberculosis with cervical lymph node tuberculosis is reported. The patient was a 20-year-old female immigrant from Vietnam and cook apprentice. Her chief complaint was left neck swelling with pain for three months. She was diagnosed with left neck lymphadenitis at a previous hospital, which suspected malignant lymphoma and referred her to our hospital. At the time of the first visit, she had left lymph swelling with tenderness and granuloma-like masses in the nasopharynx. PET-CT showed accumulations in both the swollen left neck lymph and nasopharynx. The diagnosis of this case would appear to be nasopharyngeal cancer with left and neck lymph node metastasis or nasopharyngeal tuberculosis with cervical lymph node tuberculosis in addition to malignant lymphoma. Based on some examinations (biopsy, bacteria culture, and imaging), it was diagnosed as nasopharyngeal tuberculosis with cervical lymph node tuberculosis. Therefore, she was treated with anti-tuberculosis agent in respiratory medicine.
- 29 January 2021
- Published by MDPI AG in Clinics and Practice
- Vol. 11 (1) , 43-46
Open AccessA Case of Nasopharyngeal Tuberculosis with Cervical Lymph Node Tuberculosis Suspected of Cervical Malignant Disease at the First Examination
A case of nasopharyngeal tuberculosis with cervical lymph node tuberculosis is reported. The patient was a 20-year-old female immigrant from Vietnam and cook apprentice. Her chief complaint was left neck swelling with pain for three months. She was diagnosed with left neck lymphadenitis at a previous hospital, which suspected malignant lymphoma and referred her to our hospital. At the time of the first visit, she had left lymph swelling with tenderness and granuloma-like masses in the nasopharynx. PET-CT showed accumulations in both the swollen left neck lymph and nasopharynx. The diagnosis of this case would appear to be nasopharyngeal cancer with left and neck lymph node metastasis or nasopharyngeal tuberculosis with cervical lymph node tuberculosis in addition to malignant lymphoma. Based on some examinations (biopsy, bacteria culture, and imaging), it was diagnosed as nasopharyngeal tuberculosis with cervical lymph node tuberculosis. Therefore, she was treated with anti-tuberculosis agent in respiratory medicine.
- 1 January 2021
- Published by The Society of Practical Otolaryngology in Practica Oto-Rhino-Laryngologica
- Vol. 114 (11) , 818-819
A Parotid Sialocle due to Stenon’s Duct Injury of Face Multiple Stabs
- 1 January 2021
- Published by The Society of Practical Otolaryngology in Practica Oto-Rhino-Laryngologica
- Vol. 114 (11) , 818-819
A Parotid Sialocle due to Stenon’s Duct Injury of Face Multiple Stabs